Hemolytic-uremic syndrome future or investigational therapies: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
== Future or Investigational Therapies == | == Future or Investigational Therapies == | ||
:*[[ASA]] and [[dipyridamole]] not effective alone, | :*[[ASA]] and [[dipyridamole]] not effective alone,benefit when added to [[plasma]] [[Exchange transfusion|exchange]] | ||
:*In poorly responsive or resistant disease, INCREASE PLASMA EXCHANGE | :*In poorly responsive or resistant disease, INCREASE PLASMA EXCHANGE | ||
:*Then consider: | :*Then consider: | ||
::* [[prednisone]] (1 mg/kg per day) | ::* [[prednisone]] (1 mg/kg per day) | ||
::* [[methylprednisolone]] (125 mg IV bid) | ::* [[methylprednisolone]] (125 mg [[IV]] bid) | ||
::*[[Vincristine]] | ::*[[Vincristine]] | ||
::*IVIG | ::*[[IVIG]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 14:58, 23 August 2018
Hemolytic-uremic syndrome Microchapters |
Differentiating Hemolytic-uremic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hemolytic-uremic syndrome future or investigational therapies On the Web |
American Roentgen Ray Society Images of Hemolytic-uremic syndrome future or investigational therapies |
FDA on Hemolytic-uremic syndrome future or investigational therapies |
CDC on Hemolytic-uremic syndrome future or investigational therapies |
Hemolytic-uremic syndrome future or investigational therapies in the news |
Blogs on Hemolytic-uremic syndrome future or investigational therapies |
Risk calculators and risk factors for Hemolytic-uremic syndrome future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Sogand Goudarzi, MD [2]
Overview
Future or Investigational Therapies
- ASA and dipyridamole not effective alone,benefit when added to plasma exchange
- In poorly responsive or resistant disease, INCREASE PLASMA EXCHANGE
- Then consider:
- prednisone (1 mg/kg per day)
- methylprednisolone (125 mg IV bid)
- Vincristine
- IVIG